Built on groundbreaking research from Israel ’s Weizmann Institute of Science, Promise Bio developed the first cloud-based platform for broad epiproteomics, helping researchers uncover disease ...

Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution.

Free-to-attend conference takes place at AstraZeneca in Gothenburg, Sweden from 6–7 May Programme to focus on advancement of animal-replacement technologies and transition towards human-first, ...

At the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena, a new research group led by experimental biologist Dr Dennis de Bakker began work in January 2026. This was made possible by ...

As routine labs, imaging, and information from wearables and the environment stream in, a digital twin can model trajectories and suggest next actions, turning diagnostics into a living operating ...

BioVenic, a leading innovator in animal biotechnology and life sciences, is proud to announce the launch of its expanded suite of animal metabolomics solutions.

Researchers have developed a capsule-based method that makes it possible to analyze the same cell through multiple experimental steps. The technology overcomes a long-standing limitation in cell ...

A research team from the Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) has developed an innovative AI-based cardiovascular risk ...

Scientists discovered 2.3 million conserved non-coding sequences—some hundreds of millions of years old—using Conservatory, a new comparative plant genomics platform.

That is what stands out about The World Financial Review’s new power rankings covering 11 longevity startups. The list, published March 11, 2026, does more than spotlight companies. It suggests that ...